组织蛋白酶B
组织蛋白酶D
组织蛋白酶L
抗原
免疫学
癌症研究
主要组织相容性复合体
医学
作者
Terry Y Nakagawa,William H. Brissette,Paul D. Lira,R. J. Griffiths,Nina Petrushova,Jeffrey L. Stock,John D. McNeish,Susan Eastman,Edward D Howard,Sally R. M. Clarke,Edward F. Rosloniec,Eileen A. Elliott,Alexander Y. Rudensky
出处
期刊:Immunity
[Cell Press]
日期:1999-02-01
卷期号:10 (2): 207-217
被引量:370
标识
DOI:10.1016/s1074-7613(00)80021-7
摘要
Cathepsins have been implicated in the degradation of proteins destined for the MHC class II processing pathway and in the proteolytic removal of invariant chain (Ii), a critical regulator of MHC class II function. Mice lacking the lysosomal cysteine proteinase cathepsin S (catS) demonstrated a profound inhibition of Ii degradation in professional APC in vivo. A marked variation in the generation of MHC class II-bound Ii fragments and presentation of exogenous proteins was observed between B cells, dendritic cells, and macrophages lacking catS. CatS-deficient mice showed diminished susceptibility to collagen-induced arthritis, suggesting a potential therapeutic target for regulation of immune responsiveness.
科研通智能强力驱动
Strongly Powered by AbleSci AI